A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.
Mesial temporal lobe epilepsy, which accounts for about 80% of all temporal lobe seizures, involves seizures starting in or near a part of the brain called the hippocampus, which controls memory and ...
In a retrospective cohort, a clinical heuristic composed of eight binary variables helped identify which patients with medial temporal lobe epilepsy (MTLE) were best suited for stereotactic laser ...
Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of brain cells. A new study from researchers at Georgetown University Medical ...
In temporal lobe epilepsy — a common and debilitating form of the disorder — seizures often cause those affected to lose consciousness. But why that happens has been unclear. In a new study, Yale ...
People with temporal lobe epilepsy in particular often wander around aimlessly and unconsciously after a seizure. Researchers at the University Hospital Bonn (UKB), the University of Bonn, and the ...
Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results